exagen-logo-440x386-1.jpg
Exagen Inc. Reports Second Quarter 2022 Results
04 août 2022 16h05 HE | Exagen Inc.
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2022. ...
Exagen logo_440x386 (1).jpg
Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference
20 avr. 2022 16h05 HE | Exagen Inc.
SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2...
Exagen logo_440x386 (1).jpg
Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021
21 oct. 2021 16h05 HE | Exagen Inc.
SAN DIEGO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today it will be presenting new scientific research at the...
Exagen Points the Way for Patients with Difficult-to-Diagnose Disease
02 mai 2018 09h55 HE | Exagen Diagnostics, Inc.
San Diego, Ca and Albuquerque, NM, May 02, 2018 (GLOBE NEWSWIRE) -- May is “Lupus Awareness Month” and according to the Lupus Foundation of America, polls show that some two thirds of Americans...